Navigation Links
Genstruct Expands Team with New VP of Engineering
Date:10/20/2008

CAMBRIDGE, Mass., Oct. 20 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better understand large-scale biology, announced today that it has appointed Julian Ray, Ph.D. as vice president of Engineering. In his new role, Dr. Ray will be responsible for managing the continued evolution of the Genstruct technology platform, customer platforms and the company's IT functions.

"Julian's role is vital to the future of our company," said William Ladd, Ph.D., senior vice president, Technology Platform & Operations at Genstruct. "Our propriety computational modeling platform is used to define drug-induced efficacy and toxicity in our collaborations with pharmaceutical and biotech companies and enabled Genstruct to deliver actionable insights for these companies. By hiring Julian as a dedicated expert focused specifically on advancing our Causal Systems Modeling platform, we will be able to remain ahead of the technology curve."

"The capabilities of Genstruct's technology platform to mine large sets of literature and data, incorporate knowledge and test and validate models against experimental data is truly unique to the industry," said Dr. Ray. "I look at my new role as a great opportunity to take an already robust technology system and make further enhancements to solve the biological modeling challenges of life sciences companies."

Dr. Ray has more than 18 years of experience in designing, developing and deploying innovative solutions to challenging technology and information management systems problems. Prior to joining Genstruct, Dr. Ray was the chief technology officer (CTO) at auctionPAL, a venture-backed technology- enabled business-to-consumer services company. From 2004 to 2007, he was the co-founder and CTO for C2GLogistics, an Internet startup providing a suite of web-based services and mobile applications with a large customer base in the life sciences ind
'/>"/>

SOURCE Genstruct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Genstruct Names Louis Latino VP of Sales
2. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
3. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
4. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
5. Ventria Expands Lactoferrin Production
6. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space
7. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
8. SAFC Hitech(TM) Expands Electronic Materials Portfolio With the Introduction of Scintillation Crystal Growth Halides
9. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
10. L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion
11. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...TERDAM, November 30 Biopharmaceuti... first patients have been enrolled in its,multinat...he study is,designed to show reduction in transpla...g an allogeneic stem cell transplantation with a m...patients eligible for an allogeneic,stem cell tran...
(Date:11/30/2009)...LE, Md., Nov. 30 Novavax...pleted enrollment in the Phase II clinical study o...mmended strains) VLP vaccine candidate in healthy ...his randomized, double-blind, active-controlled st...nogenicity of two different doses (15 mcg and 60 m...
(Date:11/30/2009)...ATTLE, Nov. 30 Cell Ther...ced today that its new class of platinum-based ant...ated a stronger anti-tumor potency and activity co...unds as well as the ability to overcome cisplatin-... presented in a paper titled "Novel Bis-platinum C...
(Date:11/30/2009)... LONDON, November 30 ApaTech, ...med Europe,s fastest growing,Biotech/Pharmaceutica...itte,2009 Technology Fast 500 for EMEA (Europe, Mi...ing is based on a companies, five-year revenue gro...8% over this period. This,achievement places ApaTe...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
... PALO ALTO, Calif., Jan. 7 Intradigm Corporat... interference (RNAi) therapeutics, today,announced...its Series B,financing. Astellas Venture Managemen...stor, Lilly Ventures, also participating. The add...ancing to $21.4 million. Intradigm will,use Serie...
... UNION CITY, Calif., Jan. 7 Abaxis, Inc. (Nasdaq:...g point-of-care blood analysis instruments for bot...day that it has entered into a license agreement f...nimal health diagnostics in the professional marke...ral flow immunoassay devices and methods. , , Thi...
... TAMPA BAY, Fla., Jan. 7 News briefs concerni...egion from the Tampa Bay Partnership: , Draper... The Charles Stark Draper Laboratory bought a 41...ly where it plans to manufacture microchips for th...th St. N., should be completed,in March 2009. The...
Other Biology Technology:Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 2ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 2Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 4
(Date:11/30/2009)...30, 2009) Scientists and engineers from two of th... will come together Dec. 7 with leading academici...ping blood. , Much like moving oil through a pip... Both systems need clean, well-functioning pipes ..., to function efficiently. Both industries also ar...
(Date:11/30/2009)...invasion proteins are crucial for infection. Each ...cells, which stimulates the host cell to take up t...ert a different function, for example the regulati...esults have now been published in the current issu...iled meat is one of the sources for Listeria inf...
(Date:11/30/2009)...le to HIV research is the virus,s exquisite specia...ts, traditional tools, like the humble lab mouse, ...of researchers writing in BioMed Central,s open ac...ssault on this problem by creating a mouse that ha...cted with HIV. , George Kassiotis, from the Divi...
Breaking Biology News(10 mins):Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3It takes 2 to infect 2A reductionist approach to HIV research 2Cancer Drug May Fight Alzheimers 56418 1Wellmont HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 56416 1Wellmont HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 56416 2Wellmont HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 56416 3Wellmont HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 56416 4Wellmont HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 56416 5Reportlinker Adds Lung Cancer Therapeutics Report 56414 1Reportlinker Adds Lung Cancer Therapeutics Report 56414 2Reportlinker Adds Lung Cancer Therapeutics Report 56414 3Reportlinker Adds Lung Cancer Therapeutics Report 56414 4Reportlinker Adds Lung Cancer Therapeutics Report 56414 5Reportlinker Adds Lung Cancer Therapeutics Report 56414 6Reportlinker Adds Lung Cancer Therapeutics Report 56414 7Reportlinker Adds Lung Cancer Therapeutics Report 56414 8Reportlinker Adds Lung Cancer Therapeutics Report 56414 9Reportlinker Adds Lung Cancer Therapeutics Report 56414 10
...e is available in German . , For quite some t...o been considered the building material of choice ...drowski at the Ruhr University in Bochum has now m...surfaces) from DNA building blocks. As reported in...formed in a self-assembly process from 20 individu...
...ethanol production has increased dramatically in r... increased. New U.S. government policies require m... plans call for a viable cellulosic ethanol indust... further growth of corn acres in the near term, wi...ently, U.S. grain-based ethanol production is conc...
...ftware Is Force Multiplier for Shelbyville Police ...tional,Inc. (OTC Bulletin Board: BKYI), a leader i...ss public safety solutions, today announced the,aw...Department,("Department") for the Department,s fir...e, BIO-key,s wireless messaging and query solution...
Other Biology News:Nano-softball made of DNA 2Fueling ethanol production while protecting water quality 2Fueling ethanol production while protecting water quality 3BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency 2BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency 3
EDG-1 Western blot control from Exalpha Biologicals, Inc.
Stem Cell Expansion Media 1 from 3H Biomedical AB
Human TIMP-1 ELISpot Development Kit from R&D Systems
BD IMagnet 1 each from BD Biosciences Pharmingen
Biology Products: